Stany Zjednoczone - angielski - NLM (National Library of Medicine)

redpharm drug inc. - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin - unii:6gnt3y5lmf) - levofloxacin 750 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of levaquin® and other antibacterial drugs, levaquin® should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. levaquin® tablets/injection and oral solution are indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible strains of the designated microorganisms in the conditions listed in this section. levaquin® injection is indicated when intravenous administration offers a route of administration advantageous to the patient (e.g., patient cannot tolerate an oral dosage form). culture and susceptibility testing appropriate culture and

Kanada - angielski - Health Canada

sanofi-aventis canada inc - primaquine phosphate - tablet - 26.3mg - primaquine phosphate 26.3mg - antimalarials

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

bayer new zealand limited - omeprazole magnesium 10.3mg equivalent to 10 mg omeprazole;   - enteric coated tablet - 10 mg - active: omeprazole magnesium 10.3mg equivalent to 10 mg omeprazole   excipient: crospovidone ferrous oxide glyceryl monostearate hypromellose methacrylic acid-ethyl acrylate copolymer (1:1) hydroxypropylcellulose iron oxide yellow macrogol 6000 magnesium stearate microcrystalline cellulose polysorbate 80 purified talc sodium hydroxide sodium stearyl fumarate sugar spheres synthetic paraffin titanium dioxide triethyl citrate

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

bayer new zealand limited - omeprazole magnesium 20.6mg equivalent to 20 mg omeprazole;   - enteric coated tablet - 20 mg - active: omeprazole magnesium 20.6mg equivalent to 20 mg omeprazole   excipient: crospovidone ferrous oxide glyceryl monostearate hard paraffin hyprolose hypromellose methacrylic acid-ethyl acrylate copolymer (1:1) macrogol 6000 magnesium stearate microcrystalline cellulose polysorbate 80 purified talc sodium hydroxide sodium stearyl fumarate sugar spheres titanium dioxide triethyl citrate - the short-term relief of reflux-like symptoms in patients aged 18 years and over.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - domperidone 10mg;   - tablet - 10 mg - active: domperidone 10mg   excipient: cottonseed oil, hydrogenated hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone purified water   sodium laurilsulfate   starch - adults and adolescents weighing 35kg or more: symptomatic treatment of the dyspeptic symptom complex that may be associated with delayed gastic emptying such as epigastric sense of fullness, abdominal distension or swelling, or epigastric pain or discomfort.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 500 mg - levaquin ® is indicated in adult patients for the treatment of nosocomial pneumonia due to methicillin-susceptible staphylococcus aureus , pseudomonas aeruginosa , serratia marcescens , escherichia coli , klebsiella pneumoniae , haemophilus influenzae , or streptococcus pneumoniae . adjunctive therapy should be used as clinically indicated. where pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended [see clinical studies (14.1)] . levaquin ® is indicated in adult patients for the treatment of community-acquired pneumonia due to methicillin-susceptible staphylococcus aureus , streptococcus pneumoniae (including multi-drug-resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae , haemophilus parainfluenzae , klebsiella pneumoniae , moraxella catarrhalis , chlamydophila pneumoniae , legionella pneumophila , or mycoplasma pneumoniae [see dosage and administration (2.1) and clinical studies (14.2)] . mdrsp isolates ar

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

remedyrepack inc. - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 750 mg - levaquin ® is indicated in adult patients for the treatment of nosocomial pneumonia due to methicillin-susceptible staphylococcus aureus , pseudomonas aeruginosa , serratia marcescens , escherichia coli , klebsiella pneumoniae , haemophilus influenzae , or streptococcus pneumoniae . adjunctive therapy should be used as clinically indicated. where pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended [see clinical studies (14.1)] . levaquin ® is indicated in adult patients for the treatment of community-acquired pneumonia due to methicillin-susceptible staphylococcus aureus , streptococcus pneumoniae (including multi-drug-resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae , haemophilus parainfluenzae , klebsiella pneumoniae , moraxella catarrhalis , chlamydophila pneumoniae , legionella pneumophila , or mycoplasma pneumoniae [see dosage and administration (2.1) and clinical studies (14.2)] . mdrsp isolates ar

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 750 mg - levaquin ® is indicated in adult patients for the treatment of nosocomial pneumonia due to methicillin-susceptible staphylococcus aureus , pseudomonas aeruginosa , serratia marcescens , escherichia coli , klebsiella pneumoniae , haemophilus influenzae , or streptococcus pneumoniae . adjunctive therapy should be used as clinically indicated. where pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended [see clinical studies (14.1)] . levaquin ® is indicated in adult patients for the treatment of community-acquired pneumonia due to methicillin-susceptible staphylococcus aureus , streptococcus pneumoniae (including multi-drug-resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae , haemophilus parainfluenzae , klebsiella pneumoniae , moraxella catarrhalis , chlamydophila pneumoniae , legionella pneumophila , or mycoplasma pneumoniae [see dosage and administration (2.1) and clinical studies (14.2)] . mdrsp isolates ar

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

alvogen, inc. - primaquine phosphate (unii: h0982hf78b) (primaquine - unii:mvr3634gx1) - primaquine 26.3 mg

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

ingenus pharmaceuticals nj, llc - primaquine phosphate (unii: h0982hf78b) (primaquine - unii:mvr3634gx1) - primaquine 15 mg